BioTrends Announces Newly Expanded Oncology Division to Focus on Launch Metrics of Bristol-Myers Squibb Company’s Yervoy, Roche and Daiichi Sankyo, Inc.'s Zelboraf, Pfizer Inc.'s Xalkori and Johnson & Johnson’s Zytiga

EXTON, Pa.--(BUSINESS WIRE)--The Oncology marketplace is going through a paradigm shift with new product launches and competitive promotion vying for patient treatment share. These new marketing reports written by Oncology experts will provide essential insights into the market dynamics.